| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |